List of Orphazyme patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11304941 Use of HSP70 as a regulator of enzymatic activity	Patent 11304941 was granted and assigned to Orphazyme on April, 2022 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	11304941	April 19, 2022
‌ US Patent 11229633 Arimoclomol formulation	Patent 11229633 was granted and assigned to Orphazyme on January, 2022 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	11229633	January 25, 2022
‌ US Patent 10898476 Heat shock proteins and cholesterol homeostasis	Patent 10898476 was granted and assigned to Orphazyme on January, 2021 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	10898476	January 26, 2021
‌ US Patent 11045460 Use of Hsp70 as a regulator of enzymatic activity	Patent 11045460 was granted and assigned to Orphazyme on June, 2021 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	11045460	June 29, 2021
‌ US Patent 10543204 Use of Hsp70 as a regulator of enzymatic activity	Patent 10543204 was granted and assigned to Orphazyme on January, 2020 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	10543204	January 28, 2020
‌ US Patent 11253505 Arimoclomol for treating glucocerebrosidase associated disorders	Patent 11253505 was granted and assigned to Orphazyme on February, 2022 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	11253505	February 22, 2022
‌ US Patent 10532085 Methods for increasing intracellular activity of Hsp70	Patent 10532085 was granted and assigned to Orphazyme on January, 2020 by the United States Patent and Trademark Office.	Orphazyme	Orphazyme	United States Patent and Trademark Office	10532085	January 14, 2020
‌ US Patent 10709700 Arimoclomol formulation		Orphazyme	Orphazyme	United States Patent and Trademark Office	10709700	July 14, 2020